Table 3.
In‐hospital management and outcomes
| Overall (N = 115) | Bedside (N = 35) | Cath Lab (N = 80) | p‐value | |
|---|---|---|---|---|
| Correct IABP radiographic position | 95 (82.6%) | 29 (82.9%) | 66 (82.5%) | 0.963 |
| IABP support duration (days) | 6.0 (7.1) | 7.2 (6.3) | 5.4 (7.5) | 0.230 |
| CICU stay (days) | 13.0 (12.6) | 18.0 (11.8) | 11.1 (12.4) | 0.017* |
| In‐hospital death | 24 (20.9%) | 10 (28.6%) | 14 (17.5%) | 0.179 |
| Renal replacement therapy | 19 (16.5%) | 8 (22.9%) | 11 (13.8%) | 0.226 |
| Escalation to Impella 2.5/CP | 11 (9.6%) | 5 (14.3%) | 6 (7.5%) | 0.255 |
| Escalation to VA‐ECMO | 5 (4.3%) | 3 (8.6%) | 2 (2.5%) | 0.142 |
| IABP‐related major vascular complication | 6 (5.2%) | 2 (5.7%) | 4 (5.0%) | 0.874 |
| IABP‐related minor vascular complication | 12 (10.4%) | 4 (11.4%) | 8 (10.0%) | 0.818 |
| IABP‐related pseudoaneurysm | 6 (5.2%) | 2 (5.7%) | 4 (5.0%) | 0.874 |
| IABP‐related arterio‐venous fistula | 2 (1.7%) | 0 (0.0%) | 2 (2.5%) | 0.345 |
| IABP‐related critical limb ischemia | 7 (6.1%) | 3 (8.6%) | 4 (5.0%) | 0.461 |
| IABP‐related access‐site bleeding/hematoma | 3 (2.6%) | 1 (2.9%) | 2 (2.5%) | 0.912 |
| IABP‐related arterial dissection | 2 (1.7%) | 1 (2.9%) | 1 (1.2%) | 0.544 |
| IABP‐related stroke/TIA | 1 (0.9%) | 1 (2.9%) | 0 (0.0%) | 0.129 |
| Non‐IABP related major bleeding | 17 (14.8%) | 8 (22.9%) | 9 (11.2%) | 0.107 |
| Sepsis | 33/88 (39.8%) | 13/28 (46.4%) | 22/60 (36.7%) | 0.383 |
| LVAD implantation | 6 (5.2%) | 6 (17.1%) | 0 (0.0%) | <0.001* |
Abbreviations: IABP, intra‐aortic balloon pump; ICU, intensive care unit; LVAD, left ventricular assist device; TIA, transient ischemic attack; VA‐ECMO, venoarterial extracorporeal membrane oxygenation; Categorial variables are expressed as count and proportions, continuous variable as means (standard deviations). *Significant at the 0.05 level.